相似文献
1
Genetics of psychosis in Alzheimer's disease: a review.
J Alzheimers Dis. 2010;19(3):761-80. doi: 10.3233/JAD-2010-1274.
2
Genetics of psychosis of Alzheimer disease.
Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):27-35. doi: 10.1002/ajmg.b.32413. Epub 2016 Jan 12.
3
Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease.
Am J Geriatr Psychiatry. 2006 Apr;14(4):343-51. doi: 10.1097/01.JGP.0000192491.50802.c3.
4
Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
J Geriatr Psychiatry Neurol. 2002 Spring;15(1):24-30. doi: 10.1177/089198870201500106.
5
Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses.
Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):28-32. doi: 10.1002/ajmg.b.30219.
6
The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.
Int Psychogeriatr. 2009 Feb;21(1):78-85. doi: 10.1017/S1041610208007734. Epub 2008 Sep 25.
7
Genome-wide association study of Alzheimer's disease with psychotic symptoms.
Mol Psychiatry. 2012 Dec;17(12):1316-27. doi: 10.1038/mp.2011.125. Epub 2011 Oct 18.
8
Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.
Behav Brain Funct. 2012 Dec 27;8:62. doi: 10.1186/1744-9081-8-62.
9
Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.
J Alzheimers Dis. 2009;16(1):173-80. doi: 10.3233/JAD-2009-0950.
10
Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis.
Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):841-8. doi: 10.1002/ajmg.b.30515.
引用本文的文献
1
Exploring the Therapeutic Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) in Individuals With Alzheimer's Disease: A Comprehensive Narrative Review.
Cureus. 2025 May 27;17(5):e84885. doi: 10.7759/cureus.84885. eCollection 2025 May.
2
Searching for new drugs for the treatment of dementia-related psychosis.
Postep Psychiatr Neurol. 2021 Dec;30(4):270-277. doi: 10.5114/ppn.2021.111942. Epub 2021 Dec 21.
3
Correlations of psychological distress with plasma cytokine levels and gene mutations in acral and non-acral melanoma.
Front Psychiatry. 2022 Nov 3;13:1024206. doi: 10.3389/fpsyt.2022.1024206. eCollection 2022.
4
Association of cardiovascular risk burden with risk of dementia and brain pathologies: A population-based cohort study.
Alzheimers Dement. 2021 Dec;17(12):1914-1922. doi: 10.1002/alz.12343. Epub 2021 Jul 26.
5
Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic.
Sci Rep. 2020 Nov 18;10(1):20058. doi: 10.1038/s41598-020-77023-z.
6
Psychosis in Alzheimer's Disease.
Curr Neurol Neurosci Rep. 2020 Oct 13;20(12):57. doi: 10.1007/s11910-020-01074-y.
7
Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood.
Schizophr Res. 2019 Apr;206:82-88. doi: 10.1016/j.schres.2018.12.010. Epub 2018 Dec 21.
8
Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
Curr Alzheimer Res. 2018;15(2):187-194. doi: 10.2174/1567205014666170829114346.
9
Genetic risk for schizophrenia and psychosis in Alzheimer disease.
Mol Psychiatry. 2018 Apr;23(4):963-972. doi: 10.1038/mp.2017.81. Epub 2017 May 2.
10
Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.
Neurosci Biobehav Rev. 2017 Dec;83:713-720. doi: 10.1016/j.neubiorev.2017.02.021. Epub 2017 Feb 21.
本文引用的文献
1
Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease.
Dement Geriatr Cogn Disord. 2008;26(3):257-60. doi: 10.1159/000160958. Epub 2008 Oct 8.
2
The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.
Int Psychogeriatr. 2009 Feb;21(1):78-85. doi: 10.1017/S1041610208007734. Epub 2008 Sep 25.
3
Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease.
Neuromolecular Med. 2008;10(4):377-84. doi: 10.1007/s12017-008-8048-8. Epub 2008 Aug 12.
4
SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population.
Hum Mutat. 2008 May;29(5):769-70. doi: 10.1002/humu.20725.
5
Serotonin transporter gene polymorphism and BPSD in mild Alzheimer's disease.
J Alzheimers Dis. 2007 Nov;12(3):245-53. doi: 10.3233/jad-2007-12306.
6
A network of dopaminergic gene variations implicated as risk factors for schizophrenia.
Hum Mol Genet. 2008 Mar 1;17(5):747-58. doi: 10.1093/hmg/ddm347. Epub 2007 Nov 27.
7
Sorl1 as an Alzheimer's disease predisposition gene?
Neurodegener Dis. 2008;5(2):60-4. doi: 10.1159/000110789. Epub 2007 Nov 1.
8
Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable Alzheimer disease patients.
Dement Geriatr Cogn Disord. 2007;24(3):201-6. doi: 10.1159/000107081. Epub 2007 Aug 10.
9
Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.
Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1054-62. doi: 10.1002/ajmg.b.30549.
10
Genome-wide association. Closing the net on common disease genes.
Science. 2007 May 11;316(5826):820-2. doi: 10.1126/science.316.5826.820.
Zotero 插件